Two Bear Capital
Two Bear Capital Operations, LLC is a venture capital firm founded in 2019 and based in Whitefish, Montana, with additional offices in San Francisco and San Diego. The firm focuses on early-stage investments in companies that demonstrate disruptive innovations in sectors such as biotech, bioinformatics, healthcare information technology, machine learning, artificial intelligence, and cybersecurity. Its mission is to support technologies that provide improved solutions to pressing issues related to human health, security, and wellness, particularly in Montana and the Pacific Northwest. As a Registered Investment Adviser, Two Bear Capital aims to foster advancements that significantly enhance the quality of life through innovative approaches.
Inimmune Corp. is a biotechnology company based in Missoula, Montana, founded in 2016. The company specializes in the discovery, optimization, and development of vaccines and immunotherapeutics targeting various medical conditions, including oncology, allergic rhinitis, food allergies, autoimmune diseases, and infectious diseases. Inimmune's research focuses on innate immune receptor agonists and antagonists, aiming to provide innovative treatments for patients suffering from allergies, cancer, and upper respiratory tract infections. Through its work, Inimmune seeks to advance the field of immunomodulatory therapeutics and improve patient outcomes in diverse therapeutic areas.
VERAFĪ operates as a SaaS-based platform focused on private intelligence and due diligence, aiming to enhance fraud prevention in various sectors. The company integrates human expertise from the intelligence community with advanced machine learning technology, catering to professionals in private equity, venture capital, and commercial credit. This approach allows users to access critical intelligence efficiently, facilitating a smoother deal flow process. By addressing the needs of the corporate and human diligence markets, VERAFĪ provides tools for effective KYC (Know Your Customer), enhanced due diligence, pre-employment screening, and fraud detection, thus promoting a more secure business environment.
FYR Diagnostics, founded in 2016 and based in Missoula, Montana, focuses on developing biomarker detection technology aimed at addressing chronic diseases in both human healthcare and agriculture. The company aims to tackle significant clinical challenges by commercializing innovative technologies that enhance the prediction, diagnosis, and management of diseases. This approach targets disorders that currently suffer from inadequate treatment and diagnostic options, thereby offering potential solutions for healthcare professionals and agricultural sectors facing substantial unmet needs.
VERAFĪ operates as a SaaS-based platform focused on private intelligence and due diligence, aiming to enhance fraud prevention in various sectors. The company integrates human expertise from the intelligence community with advanced machine learning technology, catering to professionals in private equity, venture capital, and commercial credit. This approach allows users to access critical intelligence efficiently, facilitating a smoother deal flow process. By addressing the needs of the corporate and human diligence markets, VERAFĪ provides tools for effective KYC (Know Your Customer), enhanced due diligence, pre-employment screening, and fraud detection, thus promoting a more secure business environment.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.